• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性痒疹:流行病学和临床特征。

Prurigo nodularis: Epidemiology and clinical features.

机构信息

Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.

Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

J Am Acad Dermatol. 2020 Dec;83(6):1559-1565. doi: 10.1016/j.jaad.2020.04.183. Epub 2020 May 23.

DOI:10.1016/j.jaad.2020.04.183
PMID:32454098
Abstract

Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intensely pruritic, hyperkeratotic nodules that favor the extensor surfaces of the extremities and the trunk. In addition to its significant impact on quality of life, many patients with PN are recalcitrant to therapy because there are currently no therapies approved by the US Food and Drug Administration. In the first article of this 2-part continuing medical education series, we describe the broader epidemiology, patient demographics, physical examination findings, and symptoms to aid in the timely recognition and diagnosis of PN. Furthermore, we quantify the burden of comorbidities in PN by discussing the broad spectrum of systemic diseases and mental health conditions that have been associated with this condition. The second article of this 2-part series focuses on the pathogenesis of PN and provides detailed algorithms for comprehensive work-up and management.

摘要

结节性痒疹(PN)是一种慢性炎症性皮肤病,其特征为剧烈瘙痒、角化过度的结节,多见于四肢和躯干的伸展面。除了对生活质量有重大影响外,许多 PN 患者对治疗有抵触,因为目前还没有获得美国食品和药物管理局批准的疗法。在这个两部分继续医学教育系列的第一篇文章中,我们描述了更广泛的流行病学、患者人口统计学、体格检查结果和症状,以帮助及时识别和诊断 PN。此外,我们通过讨论与这种疾病相关的广泛的系统性疾病和心理健康状况,量化了 PN 合并症的负担。本系列的第二篇文章重点介绍了 PN 的发病机制,并提供了详细的综合检查和管理算法。

相似文献

1
Prurigo nodularis: Epidemiology and clinical features.结节性痒疹:流行病学和临床特征。
J Am Acad Dermatol. 2020 Dec;83(6):1559-1565. doi: 10.1016/j.jaad.2020.04.183. Epub 2020 May 23.
2
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.结节性痒疹的病理生理学、诊断和药物治疗。
Expert Rev Clin Pharmacol. 2021 Jan;14(1):67-77. doi: 10.1080/17512433.2021.1852080. Epub 2020 Dec 11.
3
Prurigo nodularis: Pathogenesis and management.结节性痒疹:发病机制与治疗。
J Am Acad Dermatol. 2020 Dec;83(6):1567-1575. doi: 10.1016/j.jaad.2020.04.182. Epub 2020 May 24.
4
INDIVIDUAL ARTICLE: Patient Journey and the Burden of Systemic Comorbidities and Sequalae in Prurigo Nodularis.个体文章:结节性痒疹患者的疾病历程及系统性共病和后遗症负担。
J Drugs Dermatol. 2023 Dec 1;22(12):SF365502s12-SF365502s14. doi: 10.36849/JDD.SF365502.
5
INDIVIDUAL ARTICLE: Prurigo Nodularis: Current Clinicopathologic Overview and Psychodermatological Perspectives.个案研究:结节性痒疹:当前的临床病理概述和精神皮肤病学观点。
J Drugs Dermatol. 2023 Dec 1;22(12):SF365502s6-SF365502s11. doi: 10.36849/JDD.SF365502.
6
A critical review of dupilumab for adult patients with prurigo nodularis.度普利尤单抗治疗成年结节性痒疹患者的批判性综述。
Expert Rev Clin Immunol. 2024 Mar;20(3):249-254. doi: 10.1080/1744666X.2023.2268291. Epub 2023 Oct 12.
7
Prevalence, incidence and treatment patterns of prurigo nodularis in England: a retrospective database analysis.英国结节性痒疹的患病率、发病率和治疗模式:一项回顾性数据库分析。
Br J Dermatol. 2024 Sep 18;191(4):548-555. doi: 10.1093/bjd/ljae207.
8
Prurigo nodularis: new insights into pathogenesis and novel therapeutics.结节性痒疹:发病机制的新见解和新疗法。
Br J Dermatol. 2024 May 17;190(6):798-810. doi: 10.1093/bjd/ljae052.
9
[Psychosomatic aspects of prurigo nodularis].[结节性痒疹的心身方面]
Hautarzt. 2014 Aug;65(8):704-8. doi: 10.1007/s00105-014-2758-7.
10
Ethnic differences and comorbidities of 909 prurigo nodularis patients.909 例结节性痒疹患者的种族差异和合并症。
J Am Acad Dermatol. 2018 Oct;79(4):714-719.e3. doi: 10.1016/j.jaad.2018.04.047. Epub 2018 May 4.

引用本文的文献

1
Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden.瑞典结节性痒疹的治疗模式、医疗资源利用及相关费用
Acta Derm Venereol. 2025 Aug 18;105:adv43730. doi: 10.2340/actadv.v105.43730.
2
Dupilumab treatment for prurigo nodularis: a retrospective study of 76 patients.度普利尤单抗治疗结节性痒疹:76例患者的回顾性研究
Postepy Dermatol Alergol. 2025 Jun 12;42(3):248-254. doi: 10.5114/ada.2025.152080. eCollection 2025 Jun.
3
Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab.
度普利尤单抗成功治疗儿童结节性特应性痒疹
Clin Cosmet Investig Dermatol. 2025 Jun 26;18:1609-1613. doi: 10.2147/CCID.S523134. eCollection 2025.
4
Generalized prurigo nodularis after dermatomal herpes zoster: Resolution with nemolizumab.带状疱疹后泛发性结节性痒疹:使用奈莫利珠单抗治愈
JAAD Case Rep. 2025 Apr 14;60:122-125. doi: 10.1016/j.jdcr.2025.04.001. eCollection 2025 Jun.
5
Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature.乌帕替尼成功治疗结节性痒疹:一例报告及文献综述
Int Med Case Rep J. 2025 May 28;18:637-644. doi: 10.2147/IMCRJ.S514339. eCollection 2025.
6
Prurigo Nodularis PaTient-Reported BurdEn of SicKness (PN TREK): A Cross-Sectional Survey of Patient-Reported Burden of Disease in Patients with PN from the US.结节性痒疹患者报告的疾病负担(PN TREK):一项来自美国的结节性痒疹患者疾病负担报告的横断面调查。
Adv Ther. 2025 Jul;42(7):3455-3471. doi: 10.1007/s12325-025-03217-4. Epub 2025 May 29.
7
Clinical characteristics and disease burden in Chinese patients with prurigo nodularis.中国结节性痒疹患者的临床特征和疾病负担
Arch Dermatol Res. 2025 Apr 19;317(1):727. doi: 10.1007/s00403-025-04229-4.
8
Current Status of Prurigo Nodularis in Japan: A Retrospective Study Using a Health Insurance Claims Database.日本结节性痒疹的现状:一项使用健康保险理赔数据库的回顾性研究
J Clin Med. 2025 Mar 11;14(6):1872. doi: 10.3390/jcm14061872.
9
Kyrle disease: a systematic review of clinical features, diagnostic approaches, dermatoscopic insights, systemic associations, and therapeutic strategies.Kyrle病:临床特征、诊断方法、皮肤镜观察、全身关联及治疗策略的系统评价
Arch Dermatol Res. 2025 Mar 23;317(1):622. doi: 10.1007/s00403-025-04067-4.
10
Efficacy and Safety of Nemolizumab in Patients With Prurigo Nodularis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.奈莫利珠单抗治疗结节性痒疹患者的疗效和安全性:一项随机对照试验的系统评价和荟萃分析
Cureus. 2025 Feb 9;17(2):e78761. doi: 10.7759/cureus.78761. eCollection 2025 Feb.